Source: startupticker

Nagi Bioscience: Nagi Bioscience launches first all-in-one laboratory platform

SydLab One is the first all-in-one laboratory platform capable of performing end-to-end bioassays and high-content screening of drugs and chemicals on micro-organisms in a fully automated and standardized way. Engineered by EPFL spin-off Nagi Bioscience, the technology is now available in the market.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Matteo Cornaglia's photo - Co-Founder & CEO of Nagi Bioscience

Co-Founder & CEO

Matteo Cornaglia

CEO Approval Rating

100/100

Read more